Tuesday, January 9, 2024
November 10 - 15, 2023; San Diego, California
Novel Solutions Needed to Boost Pediatric Rheum Recruitment
Researchers Better Understand RA-Associated ILD
Young Rheum Patients Report Gaps in Sexual Health Counseling
ACR 2023
Rheumatology Patients Prefer Office Visits to Telemedicine
ACR 2023
Conditional Recommendations Rule in New SARD ILD Guidelines
Telitacicept Shows Efficacy, Safety in MTX-Resistant RA
ACR 2023
Abatacept Slows Progression to RA, Phase 2b Trial Finds
ACR 2023
Benralizumab Proves Noninferior to Mepolizumab for EGPA
Risks Quantified in Medically Optimized Pregnancy With Lupus
ACR 2023
Telemedicine Offers Solution for No-Show Appointments
ACR 2023
IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA
ACR 2023
Novel Blood Test Can Detect Rheumatoid Arthritis
ACR 2023
Study Takes Fine-Grained Look at MACE Risk With GCs in RA
ACR 2023
Split-Dose Methotrexate Speeds RA Response Over Single Dose
ACR 2023
First Referral Guide Issued for Axial Spondyloarthritis
ACR 2023
Apremilast Beats Placebo in Early PsA Affecting Few Joints
Vasculitis Gives Higher Risk for Adverse Pregnancy Outcomes
ACR 2023
AI Tool Perfect in Study of Inflammatory Diseases
ACR 2023
TNF Inhibitors May Be OK for Treating RA-ILD
ACR 2023
TNF Blockers Not Associated With Poorer Pregnancy Outcomes
ACR 2023
Pregnancy in Rheumatic Disease Quadruples CVE Risk
ACR 2023
Pregnancies With Low Anti-SSA/Ro: Forgo Heart Monitoring?
ACR 2023
Obinutuzumab Promotes Renal Preservation in Lupus Nephritis
Medscape Rheumatology©
